Scinovex
articleTop 10% cited

FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor

Experimental Cell Research · 1998 · Vol. 241(1) · pp. 126–133
Hidenori NakajimaYoung Bae KimHiroshi TeranoMinoru YoshidaSueharu Horinouchi
Histone Deacetylase Inhibitors ResearchSignaling Pathways in DiseaseSynthetic Organic Chemistry MethodsTrichostatin AHistone deacetylase inhibitorHistone deacetylaseBiologyHistone deacetylase 5ChromatinHDAC11Histone deacetylase 2HDAC10Acetylation

MeSH terms

AcetylationAnti-Bacterial AgentsAntibiotics, AntineoplasticCell DivisionEnzyme InhibitorsHistonesHumansHydroxamic AcidsPeptides, CyclicPromoter Regions, GeneticSimian virus 40Transcription, GeneticTumor Cells, CulturedTranscriptional ActivationDepsipeptides
Citations
487
FWCI
8.16
field-weighted impact
References
62
Percentile
98%
vs. same field & year
Citations per year
Cited by
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
JNCI Journal of the National Cancer Institute · 2000 · 1,162 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor · Scinovex